港股異動 | 中環控股(1735.HK)大漲14%創新高價 攜手京東深化產業鏈優勢
格隆匯1月20日丨中環控股(1735.HK)漲幅擴大至超14%,報10.6港元創歷史新高價,暫成交2762萬港元遠超近期成交額,總市值超110億港元。公司再度與京東攜手共同設立合資公司,深入發展智慧物流研發、物流總部孵化、雲商、雲倉、農村電商、冷鏈及孵化配套的優勢,以數字化轉型加速其現代化水平。據悉,自去年11月份以來,中環控股在精進多元化業務上頻頻發力,先是與京東產發形成戰略合作伙伴關係,助力其產業整合服務能力,然後與翰林億訊訂立戰略投資意向書,在原有科技板塊產業鏈進一步拓展。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.